1-(3-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido(3,4-b)indole-3-carboxylic acid,
NED 19,
NED-19,
trans-Ned 19,
1354235-96-3,
Ned-19,
trans-Ned-19,
(1R,3S)-1-(3-((4-(2-Fluorophenyl)piperazin-1-yl)methyl)-4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid,
(1R,3S)-1-(3-{[4-(2-fluorophenyl)piperazin-1-yl]methyl}-4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylic acid,
(1R,3S)-1-[3-[[4-(2-fluorophenyl)piperazin-1-yl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid,
NAADP antagonist,
AC1LRT2N,
CHEMBL1222013,
SCHEMBL20162481,
AOB5360,
CHEBI:138526,
ZINC57316927,
AKOS024457895,
AS-16875,
J-006694,
Nicotinic acid adenine dinucleotide phosphate antagonist,
66R,
Ned 19,
C539827,
1-(3-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-4-methoxyphenyl)-2,3,4,9-tetrahydro-1h-pyrido(3,4-b)indole-3-carboxylic acid,